Lucid Diagnostics regains Nasdaq minimum bid price compliance

Lucid Diagnostics Inc.

Received Nasdaq notification on Feb 24, 2025 confirming compliance with $1 minimum bid price rule.
Closing bid price was $1 or greater for 11 consecutive trading days from Feb 7 to Feb 21, 2025.
Company had been non-compliant since June 2024 and received a 180-day extension through June 16, 2025.
Compliance regained under Nasdaq Listing Rule 5550(a)(2); delisting risk removed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.